Ultraviolet Light-Induced G2 Phase Cell Cycle Checkpoint Blocks Cdc25-Dependent Progression Into Mitosis

Total Page:16

File Type:pdf, Size:1020Kb

Ultraviolet Light-Induced G2 Phase Cell Cycle Checkpoint Blocks Cdc25-Dependent Progression Into Mitosis Oncogene (1997) 15, 749 ± 758 1997 Stockton Press All rights reserved 0950 ± 9232/97 $12.00 Ultraviolet light-induced G2 phase cell cycle checkpoint blocks cdc25-dependent progression into mitosis BG Gabrielli, JM Clark, AK McCormack and KAO Ellem Queensland Cancer Fund Research Laboratory, Joint Oncology Program, Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Herston, Queensland 4029, Australia In response to low doses of ultraviolet (U.V.) radiation, kinase), and is essential for the catalytic activity of cells undergo a G2 delay. In this study we have shown cdc2, whereas phosphorylation of Thr14 and Tyr15 is that the G2 delay results in the accumulation of inactive inhibitory, and catalysed by a member of the wee1/ forms of cyclin B1/cdc2 and both the G2 and mitotic mik1 family of kinases (Morgan, 1995). The latently complexes of cyclin A/cdk. This appears to be through a active form of cyclin B/cdc2 is maintained in the block in the cdc25-dependent activation of these cytoplasm until prophase, when the majority is complexes. The expression and localisation of cyclin A translocated into the nucleus (Pines and Hunter, and cyclin B1/cdk complexes are similar in U.V.-induced 1991; Bailly et al., 1992). At the same time, the G2 delay and normal early G2 phase cells. Cdc25B and inhibitory Thr14 and Tyr15 phosphates are removed cdc25C also accumulate to normal G2 levels in U.V. by a member of the cdc25 family of dual speci®city irradiated cells, but the mitotic phosphorylation asso- phosphatases, and fully active cyclin B/cdc2 is able to ciated with increased activity of both cdc25B and cdc25C perform its many mitotic functions. is absent. The cdc25B accumulates in the nucleus of U.V. In yeast only a single form of cdc25 exists, but in irradiated cells and in normal G2 phase cells. Thus the mammalian systems three isoforms have been identi®ed block in cyclin B/cdc2 activation is in part due to the (Gabrielli, 1994). Cdc25A has been demonstrated to physical separation of cyclin B/cdc2, localised in the regulate progression into S phase, while both cdc25B cytoplasm, from the cdc25B and cdc25C phosphatases and cdc25C have roles in the G2/M transition (Millar localised in the nucleus. The data positions the U.V.- et al., 1991; Jinno et al., 1994; Gabrielli et al., 1996). induced G2 checkpoint at either the S/G2 transition or The activity of cdc25 is regulated at both a early G2 phase, prior to the activation of cyclin A/cdk2. translational and post-translational level. Cdc25C is expressed at a constant level throughout the cell cycle, Keywords: cdc25; cell cycle checkpoint; U.V. while the expression of cdc25A and cdc25B has been demonstrated to be cell cycle dependent in some cell lines (Jinno et al., 1994; Gabrielli et al., 1996). The activity of both cdc25A and cdc25C is further Introduction modulated by phosphorylation (Homan et al., 1993; Homann et al., 1994). Progression through the cell cycle is regulated by the A further level of regulation of the cyclin/cdks has ordered activation of cyclin dependent kinases (cdks). been identi®ed, through the binding of low molecular In yeast, a single cdk, cdc2/CDC28, associates with weight protein inhibitors of these complexes. Two multiple cyclin partners to regulate both the START families of these proteins have been identi®ed, the and G2/M checkpoints, whereas in higher eukaryotes, p21Cip1 family including p21Cip1,p27Kip1 and p57Kip2, and a large family of cdks have so far been identi®ed, each the p16CDKN2A family including p16CDKN2A,p15CDKN2B, of which appears to regulate discrete cell cycle p18CDKN2C and p19CDKN2D (Sherr and Roberts, 1995). functions (Meyerson et al., 1992; van den Heuvel and The members of the p21 family bind to a wide range of Harlow, 1993). The best characterised in terms of cyclin/cdks, whereas the p16 family proteins have a function and regulation is cyclin B/cdc2, the prototypic much more restricted speci®city, binding only to cyclin cyclin/cdk. This complex was ®rst puri®ed from D/cdk4 and cdk6 (Sherr and Roberts, 1995). These Xenopus eggs as maturation promoting factor (MPF), proteins appear to respond to extracellular in¯uences which was the only factor required to initiate mitosis to produce cell cycle delays, for example, increased when injected into prophase arrested frog oocytes expression of p21 is induced by exposure to ionising (Lohka et al., 1988; Gautier et al., 1988). The histone radiation and is involved in a G1 delay (Dulic et al., kinase activity of cyclin B/cdc2 is regulated through a 1994), while p16 induced by irradiation with ultraviolet complex series of protein associations, phosphoryla- (U.V.) light is correlated with a G2 delay (Wang et al., tions and dephosphorylations. Cyclin B is synthesised 1996). during S and G2 phases, and immediately binds to the Exposure of cells to low doses of U.V. light catalytically inactive cdc2 monomer in the cytoplasm. produces delays in G1, S and G2/M phases of the Upon association with cyclin B, the cdc2 subunit cell cycle, depending on the dose and cell type used (Lu undergoes a series of phosphorylations. The phosphor- and Lane, 1993; Wang and Ellem, 1994; Barker et al., ylation of Thr 161 is catalysed by CAK (cdk activating 1995; Petrocelli et al., 1996; Poon et al., 1996). A role for p53-induced expression of p21, and the redistribu- Correspondence: B G Gabrielli tion of p27 among G1 and S phase cyclin/cdks in U.V.- Received 21 November 1996; revised 6 May 1997; accepted 6 May induced G1 and possibly S phase delays has been 1997 demonstrated (Lu and Lane, 1993; Barker et al., 1995; U.V. induced G2 delay BG Gabrielli et al 750 Poon et al., 1995; Petrocelli et al., 1996). The inhibitory was complexed with cyclin B1 to the same extent as in tyrosine phosphorylation of cdk4 has also been normal S/G2 cells, and that the cdc2 was predomi- implicated in the U.V.-induced G1 delay (Terada et nantly the slower migrating, Thr14 Tyr15 phosphory- al., 1995). The U.V.-induced G2 delay is independent lated form, which was converted to the faster of p53 function (Herzinger et al., 1995; Wang et al., migrating, dephosphorylated, active form at mitosis 1996), and involves a block in the cdc25-dependent (Figure 3a). This was con®rmed by phosphotyrosine activation of cyclin B/cdc2 (Herzinger et al., 1995; immunoblotting of the same cyclin B1 immunopreci- Poon et al., 1996). In this report we show that the pitates, which showed high levels of phosphotyrosine U.V.-induced G2 delay is mediated through a block in on cdc2 in both U.V. irradiated G2 delayed and the cdc25-dependent activation of cyclin B1/cdc2, normal S/G2 cyclin B1/cdc2 complexes (Figure 3b). cyclin A/cdk2 and cyclin A/cdc2, and that this block This suggested that the G2 delay was due to a block in occurs at the S/G2 transition or early G2. The block in the cdc25-dependent activation of the cyclin B1/cdc2 cdc25 function is not due to a reduction in the levels of either cdc25B or cdc25C proteins, but rather to the nuclear accumulation of cdc25B, and the inhibition of mitotic phosphorylation and activation of both cdc25B and cdc25C. Results Activation and nuclear translocation of the cyclin B1/ cdc2 complex is blocked by U.V. irradiation In response to low doses of U.V.C., HeLa cells are delayed in S and G2/M phases of the cell cycle (Wang and Ellem, 1994). Irradiation of an asynchronously growing population of the melanoma cell line A2058 also resulted in an accumulation of cells in G2/M (Figure 1a). No signi®cant accumulation or delay of cells in S phase was observed with this cell line, which was in contrast to HeLa cells irradiated under identical conditions. Following a delay of up to 20 h in G2/M, the cells recommenced progression through the cell cycle at 36 h after irradiation, which can be seen by a sharp increase in G1 and concomitant decrease in G2/ M phase cells at this time point (Figure 1b). We have investigated further the nature of the G2/M delay in HeLa and A2058 cell lines. The expression and activity of cyclin B1/cdc2, a key regulator of entry into mitosis, was analysed by immunoblotting and assaying the immunoprecipitated kinase from lysates of asynchronously growing HeLa cells (AS) which are 60% G1 phase cells, U.V. irradiated G2 delayed cells (U.V.), and late S/G2 (G2) and G2/M (M) cells from a thymidine synchrony (see Materials and methods). Immunoblotting with an anti-cyclin B1 antibody showed that cyclin B1 accumulated to normal G2 levels in the U.V. irradiated G2 delayed cells (Figure 2a), but only the G2/M phase cyclin B1/cdc2 was catalytically active (Figure 2b). Analysis of samples of similarly treated populations of A2058 cells again showed normal G2 phase accumulation of cyclin B1 and block in activation of the cyclin B1/cdc2 complex in the U.V. irradiated G2 delayed cells as was seen in HeLa (Figure 2c and d). Indirect immuno¯uorescence showed that the U.V. irradiated G2 delayed HeLa cells accumulated high levels of cyclin B1 in the cytoplasm, as in normal G2 phase cells (Pines and Hunter, 1991; Bailly et al., 1992), although due to the delay in transit through G2 in the irradiated sample up to 60% of the population showed bright cytoplasmic staining for cyclin Figure 1 U.V. irradiation of A2058 cells produces a G2 delay.
Recommended publications
  • Cyclin-Dependent Kinases and P53 Pathways Are Activated Independently and Mediate Bax Activation in Neurons After DNA Damage
    The Journal of Neuroscience, July 15, 2001, 21(14):5017–5026 Cyclin-Dependent Kinases and P53 Pathways Are Activated Independently and Mediate Bax Activation in Neurons after DNA Damage Erick J. Morris,1 Elizabeth Keramaris,2 Hardy J. Rideout,3 Ruth S. Slack,2 Nicholas J. Dyson,1 Leonidas Stefanis,3 and David S. Park2 1Massachusetts General Hospital Cancer Center, Laboratory of Molecular Oncology, Charlestown, Massachusetts 02129, 2Neuroscience Research Institute, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada, and 3Columbia University, New York, New York 10032 DNA damage has been implicated as one important initiator of ization, and DNA binding that result from DNA damage are not cell death in neuropathological conditions such as stroke. Ac- affected by the inhibition of CDK activity. Conversely, no de- cordingly, it is important to understand the signaling processes crease in retinoblastoma protein (pRb) phosphorylation was that control neuronal death induced by this stimulus. Previous observed in p53-deficient neurons that were treated with camp- evidence has shown that the death of embryonic cortical neu- tothecin. However, either p53 deficiency or the inhibition of rons treated with the DNA-damaging agent camptothecin is CDK activity alone inhibited Bax translocation, cytochrome c dependent on the tumor suppressor p53 and cyclin-dependent release, and caspase-3-like activation. Taken together, our re- kinase (CDK) activity and that the inhibition of either pathway sults indicate that p53 and CDK are activated independently alone leads to enhanced and prolonged survival. We presently and then act in concert to control Bax-mediated apoptosis. show that p53 and CDKs are activated independently on par- allel pathways.
    [Show full text]
  • Mitosis Vs. Meiosis
    Mitosis vs. Meiosis In order for organisms to continue growing and/or replace cells that are dead or beyond repair, cells must replicate, or make identical copies of themselves. In order to do this and maintain the proper number of chromosomes, the cells of eukaryotes must undergo mitosis to divide up their DNA. The dividing of the DNA ensures that both the “old” cell (parent cell) and the “new” cells (daughter cells) have the same genetic makeup and both will be diploid, or containing the same number of chromosomes as the parent cell. For reproduction of an organism to occur, the original parent cell will undergo Meiosis to create 4 new daughter cells with a slightly different genetic makeup in order to ensure genetic diversity when fertilization occurs. The four daughter cells will be haploid, or containing half the number of chromosomes as the parent cell. The difference between the two processes is that mitosis occurs in non-reproductive cells, or somatic cells, and meiosis occurs in the cells that participate in sexual reproduction, or germ cells. The Somatic Cell Cycle (Mitosis) The somatic cell cycle consists of 3 phases: interphase, m phase, and cytokinesis. 1. Interphase: Interphase is considered the non-dividing phase of the cell cycle. It is not a part of the actual process of mitosis, but it readies the cell for mitosis. It is made up of 3 sub-phases: • G1 Phase: In G1, the cell is growing. In most organisms, the majority of the cell’s life span is spent in G1. • S Phase: In each human somatic cell, there are 23 pairs of chromosomes; one chromosome comes from the mother and one comes from the father.
    [Show full text]
  • The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression
    International Journal of Molecular Sciences Review The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression Tingting Zou and Zhenghong Lin * School of Life Sciences, Chongqing University, Chongqing 401331, China; [email protected] * Correspondence: [email protected] Abstract: The cell cycle is a collection of events by which cellular components such as genetic materials and cytoplasmic components are accurately divided into two daughter cells. The cell cycle transition is primarily driven by the activation of cyclin-dependent kinases (CDKs), which activities are regulated by the ubiquitin-mediated proteolysis of key regulators such as cyclins, CDK inhibitors (CKIs), other kinases and phosphatases. Thus, the ubiquitin-proteasome system (UPS) plays a pivotal role in the regulation of the cell cycle progression via recognition, interaction, and ubiquitination or deubiquitination of key proteins. The illegitimate degradation of tumor suppressor or abnormally high accumulation of oncoproteins often results in deregulation of cell proliferation, genomic instability, and cancer occurrence. In this review, we demonstrate the diversity and complexity of the regulation of UPS machinery of the cell cycle. A profound understanding of the ubiquitination machinery will provide new insights into the regulation of the cell cycle transition, cancer treatment, and the development of anti-cancer drugs. Keywords: cell cycle regulation; CDKs; cyclins; CKIs; UPS; E3 ubiquitin ligases; Deubiquitinases (DUBs) Citation: Zou, T.; Lin, Z. The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression. 1. Introduction Int. J. Mol. Sci. 2021, 22, 5754. https://doi.org/10.3390/ijms22115754 The cell cycle is a ubiquitous, complex, and highly regulated process that is involved in the sequential events during which a cell duplicates its genetic materials, grows, and di- Academic Editors: Kwang-Hyun Bae vides into two daughter cells.
    [Show full text]
  • A Haploid Genetic Screen Identifies the G1/S Regulatory Machinery As a Determinant of Wee1 Inhibitor Sensitivity
    A haploid genetic screen identifies the G1/S regulatory machinery as a determinant of Wee1 inhibitor sensitivity Anne Margriet Heijinka, Vincent A. Blomenb, Xavier Bisteauc, Fabian Degenera, Felipe Yu Matsushitaa, Philipp Kaldisc,d, Floris Foijere, and Marcel A. T. M. van Vugta,1 aDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, 9723 GZ Groningen, The Netherlands; bDivision of Biochemistry, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; cInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research, Proteos#3-09, Singapore 138673, Republic of Singapore; dDepartment of Biochemistry, National University of Singapore, Singapore 117597, Republic of Singapore; and eEuropean Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, 9713 AV Groningen, The Netherlands Edited by Stephen J. Elledge, Harvard Medical School, Boston, MA, and approved October 21, 2015 (received for review March 17, 2015) The Wee1 cell cycle checkpoint kinase prevents premature mitotic Wee1 kinase at tyrosine (Tyr)-15 to prevent unscheduled Cdk1 entry by inhibiting cyclin-dependent kinases. Chemical inhibitors activity (5, 6). Conversely, timely activation of Cdk1 depends on of Wee1 are currently being tested clinically as targeted anticancer Tyr-15 dephosphorylation by one of the Cdc25 phosphatases drugs. Wee1 inhibition is thought to be preferentially cytotoxic in (7–10). When DNA is damaged, the downstream DNA damage p53-defective cancer cells. However, TP53 mutant cancers do not response (DDR) kinases Chk1 and Chk2 inhibit Cdc25 phos- respond consistently to Wee1 inhibitor treatment, indicating the phatases through direct phosphorylation, which blocks Cdk1 existence of genetic determinants of Wee1 inhibitor sensitivity other activation (11–13).
    [Show full text]
  • Targeting the WEE1 Kinase As a Molecular Targeted Therapy for Gastric Cancer
    www.impactjournals.com/oncotarget/ Oncotarget, Vol. 7, No. 31 Research Paper Targeting the WEE1 kinase as a molecular targeted therapy for gastric cancer Hye-Young Kim1,2, Yunhee Cho1,3, HyeokGu Kang1,3, Ye-Seal Yim1,3, Seok-Jun Kim1,3, Jaewhan Song2, Kyung-Hee Chun1,3 1Department of Biochemistry & Molecular Biology, Yonsei University College of Medicine, Seodaemun-gu, Seoul 03722, Korea 2Department of Biochemistry, College of Life Science and Biotechnology, Seodaemun-gu, Seoul 03722, Korea 3Brain Korea 21 PlusProject for Medical Science, Yonsei University, Seodaemun-gu, Seoul 03722, Korea Correspondence to: Kyung-Hee Chun, email: [email protected] Keywords: WEE1, AZD1775 (MK-1775), 5-FU, Paclitaxel, gastric cancer Received: September 07, 2015 Accepted: May 28, 2016 Published: June 23, 2016 ABSTRACT Wee1 is a member of the Serine/Threonine protein kinase family and is a key regulator of cell cycle progression. It has been known that WEE1 is highly expressed and has oncogenic functions in various cancers, but it is not yet studied in gastric cancers. In this study, we investigated the oncogenic role and therapeutic potency of targeting WEE1 in gastric cancer. At first, higher expression levels of WEE1 with lower survival probability were determined in stage 4 gastric cancer patients or male patients with accompanied lymph node metastasis. To determine the function of WEE1 in gastric cancer cells, we determined that WEE1 ablation decreased the proliferation, migration, and invasion, while overexpression of WEE1 increased these effects in gastric cancer cells. We also validated the clinical application of WEE1 targeting by a small molecule, AZD1775 (MK-1775), which is a WEE1 specific inhibitor undergoing clinical trials.
    [Show full text]
  • The Cell Cycle & Mitosis
    The Cell Cycle & Mitosis Cell Growth The Cell Cycle is G1 phase ___________________________________ _______________________________ During the Cell Cycle, a cell ___________________________________ ___________________________________ Anaphase Cell Division ___________________________________ Mitosis M phase M ___________________________________ S phase replication DNA Interphase Interphase is ___________________________ ___________________________________ G2 phase Interphase is divided into three phases: ___, ___, & ___ G1 Phase S Phase G2 Phase The G1 phase is a period of The S phase replicates During the G2 phase, many of activity in which cells _______ ________________and the organelles and molecules ____________________ synthesizes _______ molecules. required for ____________ __________ Cells will When DNA replication is ___________________ _______________ and completed, _____________ When G2 is completed, the cell is synthesize new ___________ ____________________ ready to enter the ____________________ ____________________ ____________________ ____________________ ____________________ Mitosis are divided into four phases: _____________, ______________, _____________, & _____________ Below are cells in two different phases of the cell cycle, fill in the blanks using the word bank: Chromatin Nuclear Envelope Chromosome Sister Chromatids Nucleolus Spinder Fiber Centrosome Centrioles 5.._________ 1.__________ v 6..__________ 2.__________ 7.__________ 3.__________ 8..__________ 4.__________ v The Cell Cycle & Mitosis Microscope Lab:
    [Show full text]
  • The Cell Cycle Coloring Worksheet
    Name: Date: Period: The Cell Cycle Coloring Worksheet Label the diagram below with the following labels: Anaphase Interphase Mitosis Cell division (M Phase) Interphase Prophase Cytokinesis Interphase S-DNA replication G1 – cell grows Metaphase Telophase G2 – prepares for mitosis Then on the diagram, lightly color the G1 phase BLUE, the S phase YELLOW, the G2 phase RED, and the stages of mitosis ORANGE. Color the arrows indicating all of the interphases in GREEN. Color the part of the arrow indicating mitosis PURPLE and the part of the arrow indicating cytokinesis YELLOW. M-PHASE YELLOW: GREEN: CYTOKINESIS INTERPHASE PURPLE: TELOPHASE MITOSIS ANAPHASE ORANGE METAPHASE BLUE: G1: GROWS PROPHASE PURPLE MITOSIS RED:G2: PREPARES GREEN: FOR MITOSIS INTERPHASE YELLOW: S PHASE: DNA REPLICATION GREEN: INTERPHASE Use the diagram and your notes to answer the following questions. 1. What is a series of events that cells go through as they grow and divide? CELL CYCLE 2. What is the longest stage of the cell cycle called? INTERPHASE 3. During what stage does the G1, S, and G2 phases happen? INTERPHASE 4. During what phase of the cell cycle does mitosis and cytokinesis occur? M-PHASE 5. During what phase of the cell cycle does cell division occur? MITOSIS 6. During what phase of the cell cycle is DNA replicated? S-PHASE 7. During what phase of the cell cycle does the cell grow? G1,G2 8. During what phase of the cell cycle does the cell prepare for mitosis? G2 9. How many stages are there in mitosis? 4 10. Put the following stages of mitosis in order: anaphase, prophase, metaphase, and telophase.
    [Show full text]
  • Cyclin a Triggers Mitosis Either Via Greatwall Or Cyclin B
    bioRxiv preprint doi: https://doi.org/10.1101/501684; this version posted December 20, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Cyclin A triggers Mitosis either via Greatwall or Cyclin B Nadia Hégarat(1)*, Adrijana Crncec(1)*, Maria F. Suarez Peredoa Rodri- guez(1), Fabio Echegaray Iturra(1), Yan Gu(1), Paul F. Lang(2), Alexis R. Barr(3), Chris Bakal(4), Masato T. Kanemaki(5), Angus I. Lamond(6), Bela Novak(2), Tony Ly(7)•• and Helfrid Hochegger(1)•• (1) Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton BN19RQ, UK (2) Department of Biochemistry, University of Oxford, South Park Road, Oxford OX13QU, UK (3) MRC London Institute of Medical Science, Imperial College, London W12 0NN, UK (4) The Institute of Cancer Research, London SW3 6JB, UK (5) National Institute of Genetics, Research Organization of Information and Sys- tems (ROIS), and Department of Genetics, SOKENDAI (The Graduate University of Advanced Studies), Yata 1111, Mishima, Shizuoka 411-8540, Japan. (6) Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK (7) Wellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK * Equal contribution ** Correspondence: Tony Ly: [email protected]; Helfrid Hochegger: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/501684; this version posted December 20, 2018.
    [Show full text]
  • Absence of a Measurable G2 Phase in Two Chinese Hamster Cell Lines (Cell Cycle/V79 Cells/Autoradiography) R
    Proc. Natl. Acad. Sci. USA Vol. 74, No. 4, pp. 1622-1625, April 1977 Cell Biology Absence of a measurable G2 phase in two Chinese hamster cell lines (cell cycle/V79 cells/autoradiography) R. MICHAEL LISKAY Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, Colorado 80309 Communicated by David M. Prescott, January 28, 1977 ABSTRACT Evidence is resented that demonstrates the been dipped in H20 and either air- or flame-dried. The slides absence of a measurable G2 prase in the cell cycles of two sub- were coated with NTB2 emulsion, dried, exposed for 7-28 days, lines of the Chinese hamster lung fibroblast V79. One of the sublines, in addition, lacks a detectable G1 phase, thereby pos- developed, and stained with crystal violet or Giemsa. The slides sessing a cell cycle comprised of simply two phases, DNA syn- were then scored for % labeled nuclei and % labeled meta- thesis (S) and mitosis (M). phases. An estimation of the length of the mitotic stages in V79-8 was The cell life cycle of most mammalian cells can be described obtained by examining living cells as they grew at 370 in flasks in terms of four phases (1): mitosis (M), a period between mitosis placed on the stage of an inverted phase contrast microscope. and the initiation of DNA replication (G1), DNA replication The first visible change in nuclear morphology (i.e., nuclear (S), and a period between the termination of DNA replication condensation as evidenced by a grainy appearance of the nu- and the beginning of prophase (G2).
    [Show full text]
  • Wee1 Kinase Inhibitor AZD1775 Effectively Sensitizes Esophageal Cancer to Radiotherapy
    Author Manuscript Published OnlineFirst on March 27, 2020; DOI: 10.1158/1078-0432.CCR-19-3373 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Wee1 Kinase Inhibitor AZD1775 Effectively Sensitizes Esophageal Cancer to Radiotherapy Linlin Yang1, Changxian Shen1, Cory Pettit1, Tianyun Li1, Andrew Hu1, Eric Miller1, Junran Zhang1, Steven H. Lin2, Terence M. Williams1, * 1The Ohio State University Medical Center, Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, Columbus, Ohio. 2The University of Texas MD Anderson Cancer Center, Houston, Texas. *Corresponding Author: Terence M. Williams, Department of Radiation Oncology, The Ohio State University, 460 W. 12th Avenue, BRT/Room 492, Columbus, OH 43210-1280. Phone: (614) 293-3244. Fax: 614-293-4044. E-mail: [email protected] Running title: Targeting Wee1 for radiosensitization of esophageal cancer Key words: Wee1, AZD1775, G2 checkpoint, mitotic catastrophe, esophageal cancer Conflicts of Interest: The authors report no potential conflicts of interest. Financial Disclosure Statements: All authors have no competing financial interests to disclose. Funding Support: This work was supported by the following grants: The Ohio State University Comprehensive Cancer Center (OSU-CCC), National Institutes of Health (P30 CA016058 and R01 CA198128), and National Center for Advancing Translational Sciences (KL2TR001068). 1 Downloaded from clincancerres.aacrjournals.org on September 29, 2021. © 2020 American Association for Cancer Research. Author Manuscript Published OnlineFirst on March 27, 2020; DOI: 10.1158/1078-0432.CCR-19-3373 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. ABSTRACT Purpose: Esophageal cancer (ESCA) is a deadly malignancy with a 5-year survival rate of only 5-20%, which has remained unchanged for decades.
    [Show full text]
  • Cytometry of Cyclin Proteins
    Reprinted with permission of Cytometry Part A, John Wiley and Sons, Inc. Cytometry of Cyclin Proteins Zbigniew Darzynkiewicz, Jianping Gong, Gloria Juan, Barbara Ardelt, and Frank Traganos The Cancer Research Institute, New York Medical College, Valhalla, New York Received for publication January 22, 1996; accepted March 11, 1996 Cyclins are key components of the cell cycle pro- gests that the partner kinase CDK4 (which upon ac- gression machinery. They activate their partner cy- tivation by D-type cyclins phosphorylates pRB com- clin-dependent kinases (CDKs) and possibly target mitting the cell to enter S) is perpetually active them to respective substrate proteins within the throughout the cell cycle in these tumor lines. Ex- cell. CDK-mediated phosphorylation of specsc sets pression of cyclin D also may serve to discriminate of proteins drives the cell through particular phases Go vs. GI cells and, as an activation marker, to iden- or checkpoints of the cell cycle. During unper- tify the mitogenically stimulated cells entering the turbed growth of normal cells, the timing of expres- cell cycle. Differences in cyclin expression make it sion of several cyclins is discontinuous, occurring possible to discrirmna* te between cells having the at discrete and well-defined periods of the cell cy- same DNA content but residing at different phases cle. Immunocytochemical detection of cyclins in such as in G2vs. M or G,/M of a lower DNA ploidy vs. relation to cell cycle position (DNA content) by GI cells of a higher ploidy. The expression of cyclins multiparameter flow cytometry has provided a new D, E, A and B1 provides new cell cycle landmarks approach to cell cycle studies.
    [Show full text]
  • Role of Wild Type P53 in the G2 Phase: Regulation of the G-Irradiation- Induced Delay and DNA Repair
    Oncogene (1997) 15, 2597 ± 2607 1997 Stockton Press All rights reserved 0950 ± 9232/97 $12.00 Role of wild type p53 in the G2 phase: regulation of the g-irradiation- induced delay and DNA repair Dov Schwartz, Nava Almog, Amnon Peled, Naomi Gold®nger and Varda Rotter Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel 76100 Upregulation of the p53 protein was shown to induce cell al., 1995; Wells, 1996). We have recently found that cycle arrest at the G1/S border and in some cases at the both the loss of wild type p53, or overexpression of G2/M border. Furthermore, it was suggested that p53 is mutant p53 in myeloid cells, are associated with associated with the induction of the various DNA repair polyploidity (Peled et al., 1996). This supports the pathways. Previously, we demonstrated that cells co- conclusion that p53 may play a role at the spindle expressing endogenous wild type p53 protein, together checkpoint. with dominant negative mutant p53, exhibit deregulation p53 was shown to be involved in active cellular of apoptosis, G1 arrest and delay in G2 following g- repsonses that remove DNA damage, either by repair irradiation. In the present study, we investigated the role of the damaged DNA, or by an active killing of p53 protein in the DNA damage response at the G2 (apoptosis) of cells possessing extensive, unrepairable phase. Using p53-null, wild type p53 and mutant p53- DNA damage (reviewed in Enoch and Norbury, 1995). producer cell lines, we found that the two C-terminally p53-dependent apoptosis is triggered by various stress spliced p53 forms could prevent g-irradiation induced conditions, resulting in a clastrogenic eect on the mutagenesis prior to mitosis, at the G2/M checkpoint.
    [Show full text]